Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules.
Serrano D, Johansson H, Bertelsen BE, Gandini S, Mellgren G, Thomas P, Crew KD, Kumar NB, Macis D, Aristarco V, Guerrieri-Gonzaga A, Lazzeroni M, D'Amico M, Buttiron-Webber T, Briata IM, Spinaci S, Galimberti V, Vornik LA, Villar-Sanchez E, Brown PH, Heckman-Stoddard BM, Szabo E, Bonanni B, Decensi A. Serrano D, et al. Among authors: spinaci s. J Natl Cancer Inst. 2024 Aug 7:djae183. doi: 10.1093/jnci/djae183. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39110531
Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trial.
Guerrieri-Gonzaga A, Serrano D, Thomas P, Crew KD, Kumar NB, Gandini S, Vornik LA, Lee J, Cagnacci S, Vicini E, Accornero CA, D'Amico M, Guasone F, Spinaci S, Webber TB, Brown PH, Szabo E, Heckman-Stoddard B, Bonanni B. Guerrieri-Gonzaga A, et al. Among authors: spinaci s. Contemp Clin Trials. 2021 Aug;107:106498. doi: 10.1016/j.cct.2021.106498. Epub 2021 Jul 1. Contemp Clin Trials. 2021. PMID: 34216815 Free PMC article. Clinical Trial.
Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial.
Serrano D, Gandini S, Thomas P, Crew KD, Kumar NB, Vornik LA, Lee JJ, Veronesi P, Viale G, Guerrieri-Gonzaga A, Lazzeroni M, Johansson H, D'Amico M, Guasone F, Spinaci S, Bertelsen BE, Mellgren G, Bedrosian I, Weber D, Castile T, Dimond E, Heckman-Stoddard BM, Szabo E, Brown PH, DeCensi A, Bonanni B. Serrano D, et al. Among authors: spinaci s. JAMA Oncol. 2023 May 1;9(5):664-672. doi: 10.1001/jamaoncol.2023.0089. JAMA Oncol. 2023. PMID: 36951827 Free PMC article.
Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation.
Johansson H, Guerrieri-Gonzaga A, Gandini S, Bertelsen BE, Macis D, Serrano D, Mellgren G, Lazzeroni M, Thomas PS, Crew KD, Kumar NB, Briata IM, Galimberti V, Viale G, Vornik LA, Aristarco V, Buttiron Webber T, Spinaci S, Brown PH, Heckman-Stoddard BM, Szabo E, Bonanni B, DeCensi A. Johansson H, et al. Among authors: spinaci s. NPJ Breast Cancer. 2024 Jan 18;10(1):7. doi: 10.1038/s41523-024-00616-8. NPJ Breast Cancer. 2024. PMID: 38238336 Free PMC article.
Update on Pregnancy Following Breast Cancer Diagnosis and Treatment.
Perachino M, Poggio F, Arecco L, Blondeaux E, Spinaci S, Marrocco C, Levaggi A, Lambertini M. Perachino M, et al. Among authors: spinaci s. Cancer J. 2022 May-Jun 01;28(3):176-182. doi: 10.1097/PPO.0000000000000599. Cancer J. 2022. PMID: 35594464 Review.
Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis.
Bonardi B, Massarotti C, Bruzzone M, Goldrat O, Mangili G, Anserini P, Spinaci S, Arecco L, Del Mastro L, Ceppi M, Demeestere I, Lambertini M. Bonardi B, et al. Among authors: spinaci s. Front Oncol. 2020 Oct 7;10:574669. doi: 10.3389/fonc.2020.574669. eCollection 2020. Front Oncol. 2020. PMID: 33117711 Free PMC article.
HER2-Low Breast Cancer: Where Are We?
Molinelli C, Jacobs F, Marchiò C, Pitto F, Cosso M, Spinaci S, de Azambuja E, Schettini F, Agostinetto E, Lambertini M. Molinelli C, et al. Among authors: spinaci s. Breast Care (Basel). 2022 Dec;17(6):533-545. doi: 10.1159/000527391. Epub 2022 Oct 6. Breast Care (Basel). 2022. PMID: 36590146 Free PMC article. Review.
Choosing the appropriate pharmacotherapy for breast cancer during pregnancy: what needs to be considered?
Favero D, Lapuchesky LS, Poggio F, Nardin S, Perachino M, Arecco L, Scavone G, Ottonello S, Latocca MM, Borea R, Puglisi S, Cosso M, Fozza A, Spinaci S, Lambertini M. Favero D, et al. Among authors: spinaci s. Expert Opin Pharmacother. 2023 Sep-Dec;24(18):1975-1984. doi: 10.1080/14656566.2023.2293167. Epub 2024 Jan 5. Expert Opin Pharmacother. 2023. PMID: 38179613 Review.
How to Protect Ovarian Function before and during Chemotherapy?
Arecco L, Ruelle T, Martelli V, Boutros A, Latocca MM, Spinaci S, Marrocco C, Massarotti C, Lambertini M. Arecco L, et al. Among authors: spinaci s. J Clin Med. 2021 Sep 16;10(18):4192. doi: 10.3390/jcm10184192. J Clin Med. 2021. PMID: 34575299 Free PMC article. Review.
62 results